TPN Europe 2019: USPTO and EPO aligning on AI patentability
20-06-2019
US senators release draft bill to reform section 101
31-05-2019
igorstevanovic / Shutterstock.com
A group of US legislators are pushing for a reform to section 101 of the US Patent Act which would remove the stipulation that a patent-eligible invention must be “new and useful”.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
Thom Tillis, Chris Coons, section 101, patent eligibility, nature, Patent Act, pharmaceuticals, biotech, Senate, Electronic Frontier Foundation
